Latest News On Cancer

Latest KFF Health News Stories

Mammograms at 40? Breast Cancer Screening Guidelines Spark Fresh Debate

KFF Health News Original

There is no direct evidence that screening women in their 40s will save lives, yet modeling suggests expanding routine mammography to include them might avert 1.3 deaths per 1,000. Highlighting the risk of false positives, some specialists call for a more personalized approach.

¿Mamografías a los 40? Nueva pauta para la detección del cáncer de seno genera debate

KFF Health News Original

Algunos médicos e investigadores que están interesados en un enfoque más individualizado para encontrar tumores problemáticos se muestran escépticos y plantean preguntas sobre los datos y el razonamiento detrás del cambio radical del Grupo de Trabajo de Servicios Preventivos de Estados Unidos

Para pacientes de cáncer sin seguro, conseguir atención médica es una lotería

KFF Health News Original

Los estudios demuestran que, a veces, los adultos sin seguro retrasan la atención, lo que puede perjudicar las probabilidades de supervivencia. Pero que los pacientes obtengan un seguro para cubrir el tratamiento se parece un poco al juego de la ruleta, es decir, depende de dónde vivan y del tipo de cáncer que padezcan.

For Uninsured People With Cancer, Securing Care Can Be Like Spinning a Roulette Wheel

KFF Health News Original

When uninsured people are diagnosed with cancer, accessing resources and paying for treatment can be daunting. The safety nets meant to help often fall short, say cancer physicians and health policy experts who study access to care. Some patients find it easier to play the odds.

Judge’s Decision Would Make Some No-Cost Cancer Screenings a Thing of the Past

KFF Health News Original

A U.S. District Court ruling overturned the section of the Affordable Care Act that makes preventive health services — from colonoscopies to diabetes screenings and more — available at no cost to consumers.

California’s Massive Medicaid Program Works for Some, but Fails Many Others

KFF Health News Original

Medi-Cal serves more than one-third of the state’s population — offering a dizzying range of care to a diverse population. In the new “Faces of Medi-Cal” series, California Healthline will assess the program’s strengths and weaknesses through the lives and experiences of its enrollees.

More Californians Are Dying at Home. Another Covid ‘New Normal’?

KFF Health News Original

The proportion of Californians dying at home, rather than in a hospital or nursing home, accelerated during the pandemic, a trend that has outlasted the rigid lockdowns linked to the initial shift.

Her Credit Was Ruined by Medical Debt. She’s Been Turned Away From Doctors, Jobs, and Loans

KFF Health News Original

When Penelope Wingard’s cancer went into remission, she lost her Medicaid coverage in North Carolina. Without insurance, the debts piled up for her follow-up care. She doesn’t think she’ll ever get ahead of it.

Racial Disparities in Lung Cancer Start With Research

KFF Health News Original

Improving lung cancer outcomes in Black communities will take more than lowering the screening age, experts say. Disparities are present in everything from the studies that inform when people should get checked to the availability of care in rural areas.

Despite Katie Couric’s Advice, Doctors Say Ultrasound Breast Exams May Not Be Needed

KFF Health News Original

When Katie Couric announced she had breast cancer, she urged women to get a mammogram — and, if they have dense breasts, to get supplemental screening by ultrasound. But medical experts point out that ultrasound and other auxiliary screenings haven’t been proven to do more than regular mammography in reducing mortality.

$38,398 for a Single Shot of a Very Old Cancer Drug

KFF Health News Original

Lupron, a drug patented half a century ago, treats advanced prostate cancer. It’s sold to physicians for $260 in the U.K. and administered at no charge. Why are U.S. hospitals — which may pay nearly as little for the drug — charging so much more to administer it?